| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/28/2007 | CN1938011A Pharmaceutical product containing tranilast |
| 03/28/2007 | CN1935838A Thymosin beta4 derivative and itsuse |
| 03/28/2007 | CN1935787A Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935221A Medicinal liquor for treating malignant boil |
| 03/28/2007 | CN1935210A Medicinal liquor for treating malignant boil |
| 03/28/2007 | CN1935209A Chinese for treating hand-foot tinea |
| 03/28/2007 | CN1935184A Medicinal liquor for treating malignant boil |
| 03/28/2007 | CN1935181A Animal medicament with tonifying qi and strengthening exterior, pusdraining and toxin-expelling, and its preparing method |
| 03/28/2007 | CN1935180A Medicinal liquor for treating malignant boil |
| 03/28/2007 | CN1935173A Animal medicament with expelling toxin bycooling, purging liver to brighten vision and its preparing method |
| 03/28/2007 | CN1935165A Moringaceae tablet and its producing method |
| 03/28/2007 | CN1935159A Chinese medicine composition for treating burn, empyrosis and bodysurface ulcer and its preparing method |
| 03/28/2007 | CN1935157A Medical stone emulsifiable paste for treating skin disease and its preparing method |
| 03/28/2007 | CN1935152A Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines |
| 03/28/2007 | CN1935145A Pharmaceutical use of sophora alkaloids tanate for preventing and treating skin and mucosa infection |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1934945A Use of imazalil for sunitary product and sterilizer product and its use method |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307163C Imidazole aromatic alcohol derivatives and preparation and use thereof |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1306954C Use of a pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 03/28/2007 | CN1306941C Skin preparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 03/28/2007 | CN1306937C Multifunctional compound medicine for treating burn, chemical substance combustion and its skin disease |
| 03/28/2007 | CN1306933C Anisodamine ointment for treating frostbite and sclerema neonatorum and method for preparing same |
| 03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
| 03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196162 Anti-aging and wound healing compounds |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
| 03/27/2007 | US7196083 Antiproliferative or anticarcinogenic agents comprising reaction products of ninhydrin or benzo(f)ninhydrin with 1,5-diaminotetrazole; enzyme inhibitors |
| 03/27/2007 | US7196077 Tachykinin antagonists |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195787 Topical cosmetic |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2200084C Use of aromatic halides for treating mammalian cell proliferation |
| 03/22/2007 | WO2007032643A1 A solubilized material comprising ubidecarenone, aqueous solution and process for preparation thereof |
| 03/22/2007 | WO2007032561A1 Novel inhibitor of vascular endothelial growth factor expression |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007031529A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | WO2007012379A3 Use of 3-hydroxycoumarin derivatives |
| 03/22/2007 | WO2006136713A3 Composition for treating summer dermatitis |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066661 Methods and Compositions for the Treatment of Alopecia and Other Disorders of the Pilosebaceous Apparatus |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066614 Ihibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066555 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 03/22/2007 | US20070066528 Methods and compositions for treating polycystic ovary syndrome |
| 03/22/2007 | US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065419 Using cultured keratin synthesizing cells as therapeutic tools in treatment of chronic injury; regenerative medicine; tissue engineering |
| 03/22/2007 | US20070065386 Use of oligosaccharides in cosmetic, food or dermatological compositions for stimulating the differentiation of epidermal cell |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622468A1 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 03/22/2007 | CA2622372A1 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
| 03/22/2007 | CA2621399A1 Combinations comprising a vegf receptor inhibitor and a penetration enhancer |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764104A1 Wound healing pharmaceutical composition comprising sucralfate, aluminium acetate and vitamins |
| 03/21/2007 | EP1764096A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764095A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 03/21/2007 | EP1764091A2 Improvements in or relating to amphoteric liposomes |
| 03/21/2007 | EP1764085A1 Cosmetic composition comprising argan oil |
| 03/21/2007 | EP1763500A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
| 03/21/2007 | EP1763382A1 2-oxy-acetamide compound, the uses thereof and compositions for stimulating or inducing the growth, and/or retarding the loss, of keratin fibres |
| 03/21/2007 | EP1763355A1 Use of composition comrising d-mannoheptulose and/or perseitol for the treatment and prevention of diseases linked to a modification of the innate immunity |
| 03/21/2007 | EP1763353A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR |
| 03/21/2007 | EP1763343A2 Calcium trifluoroacetate for preparing antiangiogenetic medicaments |
| 03/21/2007 | EP1633377B1 A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 03/21/2007 | EP1515710B1 Method of treating rosacea by topical application of a cyclohexane derivative |
| 03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
| 03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
| 03/21/2007 | EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine |
| 03/21/2007 | EP1399113B1 Cosmetic or dermatological composition comprising n-acylaminoamide derivatives |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | EP1206485B1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/21/2007 | CN2880085Y Collagen protein sponge of packed |
| 03/21/2007 | CN1934080A Amino acid and peptide conjugates of arylalkylic acids for cosmetic use |
| 03/21/2007 | CN1933856A Cream-gel containing ivermectin |
| 03/21/2007 | CN1933808A Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof |
| 03/21/2007 | CN1933807A Composition comprising a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound, a polymer containing said monomer compound and the use thereof |
| 03/21/2007 | CN1933805A Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides |
| 03/21/2007 | CN1931359A Orally administered peptides to ameliorate atherosclerosis |